Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-23

Clinical Trial Update: Oral Supplementation With a Formulation Based on Cetylated Fatty Acids for Post-fracture Long Bone Healing [NA]

View source ↗

Summary

Pharmanutra S.p.a. is conducting a clinical trial evaluating an oral cetylated fatty acids formulation as a supplement to support healing after femur and tibia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetylated fatty acids formulation (oral supplement) (cetylated fatty acids)

Snippet

Sponsor: Pharmanutra S.p.a. | Conditions: Fracture Femur, Fracture Tibia | NA | Status: RECRUITING